Company Registration No. 08675795 (England and Wales)
Solent Healthcare Limited
Unaudited accounts
for the year ended 30 September 2024
Solent Healthcare Limited
Unaudited accounts
Contents
Solent Healthcare Limited
Company Information
for the year ended 30 September 2024
Directors
Elmira Hossen
Rezaul Hossen
Company Number
08675795 (England and Wales)
Registered Office
4 Glen Eyre Way
Southampton
Hampshire
SO16 3GD
England
Solent Healthcare Limited
Statement of financial position
as at 30 September 2024
Intangible assets
6,423
8,564
Tangible assets
288,710
253,043
Cash at bank and in hand
24,869
280,642
Creditors: amounts falling due within one year
(386,208)
(501,400)
Net current liabilities
(75,839)
(47,982)
Net assets
219,294
213,625
Called up share capital
2
2
Profit and loss account
219,292
213,623
Shareholders' funds
219,294
213,625
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2025 and were signed on its behalf by
Rezaul Hossen
Director
Company Registration No. 08675795
Solent Healthcare Limited
Notes to the Accounts
for the year ended 30 September 2024
Solent Healthcare Limited is a private company, limited by shares, registered in England and Wales, registration number 08675795. The registered office is 4 Glen Eyre Way, Southampton, Hampshire, SO16 3GD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the year ended 30 September 2024 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 October 2022.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance
Motor vehicles
18% reducing balance
Fixtures & fittings
20% straight line
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Combined other intangible assets - 25% reducing balance
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Solent Healthcare Limited
Notes to the Accounts
for the year ended 30 September 2024
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
4
Intangible fixed assets
Other
At 30 September 2024
72,500
At 30 September 2024
66,077
At 30 September 2024
6,423
At 30 September 2023
8,564
5
Tangible fixed assets
Land & buildings
Plant & machinery
Motor vehicles
Fixtures & fittings
Total
Cost or valuation
At cost
At cost
At cost
At cost
At 1 October 2023
250,000
68,920
-
5,719
324,639
Additions
-
1,240
36,879
5,635
43,754
At 30 September 2024
250,000
70,160
36,879
11,354
368,393
At 1 October 2023
-
68,920
-
2,676
71,596
Charge for the year
-
137
6,058
1,892
8,087
At 30 September 2024
-
69,057
6,058
4,568
79,683
At 30 September 2024
250,000
1,103
30,821
6,786
288,710
At 30 September 2023
250,000
-
-
3,043
253,043
Amounts falling due within one year
Trade debtors
284,127
172,521
Solent Healthcare Limited
Notes to the Accounts
for the year ended 30 September 2024
7
Creditors: amounts falling due within one year
2024
2023
Bank loans and overdrafts
102,451
147,712
Trade creditors
25,057
25,057
Taxes and social security
24,715
31,305
Other creditors
102,706
130,062
Loans from directors
129,279
167,264
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2
2
Brought
Forward
Advance/
credit
Repaid
Carried
Forward
Directors advances, credits and guarantees
167,264
-
37,983
129,281
10
Transactions with related parties
The company is controlled by Mr Rezaul Hossen & Mrs Elmira Hossen, the company's Director. It is confirmed that the director's current account is debited with personal transactions and credited with remuneration and dividends.
11
Average number of employees
During the year the average number of employees was 28 (2023: 36).